Complete genetic suppression of polyp formation and reduction of CPG-island hypermethylation in ApcMin/+ Dnmt1-hypomorphic mice

Cancer Research

Volumn 62, Issue 5, 2002, Pages 1296-1299

  Eads, Cindy A ^a   Nickel, Andrea E ^a   Laird, Peter W ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; DNA; DNA METHYLTRANSFERASE;

ANIMAL TISSUE; ARTICLE; COLON CARCINOGENESIS; COLORECTAL CARCINOMA; CPG ISLAND; DNA METHYLATION; GENE EXPRESSION REGULATION; GENE REPRESSION; INTESTINE MUCOSA; INTESTINE POLYP; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANIMALS; CPG ISLANDS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; FEMALE; GENES, APC; INTESTINAL MUCOSA; INTESTINAL POLYPS; MALE; METAPLASIA; MICE; MICE, INBRED C57BL;

EID: 0036494563     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. DNA hypermethylation in tumorigenesis: Epigenetics joins genetics
2. Promoter-region hypermethylation and gene silencing in human cancer
3. Methylation matters
4. Cancer epigenetics comes of age
5. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality
6. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development
7. The annual report to the nation on the status of cancer, 1973-1997. With a special section on colorectal cancer
8. The ABC of APC
9. The Min (multiple intestinal neoplasia) mutation: Its effect on gut epithelial cell differentiation and interaction with a modifier system
10. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene
11. Suppression of intestinal neoplasia by DNA hypomethylation
12. Toxicity of 5-aza-2′-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation
13. De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells
14. Conversion of the lac repressor into an allosterically regulated transcriptional activator for mammalian cells
15. Reduced rates of gene loss, gene silencing, and gene mutation in dnmt1-deficient embryonic stem cells
16. Simplified mammalian DNA isolation procedure
17. A novel method for real time quantitative RT-PCR
18. Real time quantitative PCR
19. A modified and improved method for bisulphite based cytosine methylation analysis
20. CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression
21. MethyLight: A high-throughput assay to measure DNA methylation
22. Epigenetic patterns in the progression of esophageal adenocarcinoma
23. Cell lineage-specific undermethylation of mouse repetitive DNA
24. Dnmt1N/+ reduces the net growth rate and multiplicity of intestinal adenomas in C57BL/6-multiple intestinal neoplasia (Min)/+ mice independently of p53 but demonstrates strong synergy with the modifier of Min 1(AKR) resistance allele
25. Methylation of the oestrogen receptor CpG island links aging and neoplasia in human colon
26. Age-related hypermethylation of the 5′ region of MLH1 in normal colonic mucosa is associated with microsatellite-unstable colorectal cancer development
27. CpG-island methylation in aging and cancer
28. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse
29. A resistant genetic background leading to incomplete penetrance of intestinal neoplasia and reduced loss of heterozygosity in ApcMin/+ mice
30. Studies of neoplasia in the Min mouse
31. Manipulation of the mouse germline in the study of Min-induced neoplasia